Skip to Content

L'Oreal SA

OR: XPAR (FRA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
€135.00GgkyDbgfzkrypv

L’Oréal Earnings: Performance Shines, Led by Derma Skincare and Mass-Market Products

Wide-moat L’Oréal posted better-than-expected first-half results that showcased the beauty product maker’s strong brands and balanced exposure to premium and value segments globally. Revenue grew 12% and EPS up 11%, exceeding our estimates of 11% and 9%, respectively, and we will nudge up our 2023 preprint projections to incorporate the earnings update. We are maintaining our 10-year forecasts for high-single-digit sales growth and low-20s average operating margins. Shares trade in a range we'd consider fairly valued.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of OR so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center